Prospective analysis finds immune-inflammation index predicts colorectal cancer development in patients with colonic polyps, indicating potential for early detection.
SII is a promising, noninvasive biomarker for identifying patients at increased risk of CRC among those with colonic polyps. Further prospective studies are needed to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Chun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: